RLAY Dividend History & Analysis | 0% Yield
RLAY has a dividend yield of 0% and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| ABBV | 376,277 M | 3.19% | 8.74% |
| GILD | 139,926 M | 2.88% | 5.72% |
| AMGN | 152,814 M | 3.33% | 4.45% |
| HLN | 44,172 M | 1.87% | 2.56% |
| BIOG-B | 1,131 M | 1.87% | 1.82% |
| Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| BIOG-B | 1,131 M | 20.4% | 95.9% |
| GRFS | 8,687 M | 50.6% | 60.7% |
| SECARE | 676 M | 10.4% | 100% |
| AMGN | 152,814 M | 7.06% | 100% |
| ABBV | 376,277 M | 5.61% | 100% |
Similar Stocks with Attractive Dividends - Compare RLAY Dividends with its Peer-Group
3.19% Yield
3.33% Yield
2.88% Yield
1.79% Yield
RLAY Dividend History: as of September 2025
No dividends paid yet.RLAY Dividend FAQ
Relay Therapeutics, Inc. is a clinical-stage precision medicine company revolutionizing the drug discovery process with a focus on targeted oncology and genetic disease indications. The companys innovative approach leverages computational modeling capabilities to analyze protein motion, enabling the development of novel small molecule therapeutics. With a robust pipeline, Relay Therapeutics is advancing multiple product candidates, including RLY-2608, a pan-mutant and isoform-selective PI3Kα inhibitor, and lirafugratinib (RLY-4008), a receptor tyrosine kinase inhibitor, among others.
What is the Dividend Yield of RLAY?
As of September 2025, RLAY`s dividend yield is 0.00%. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 3.99.Does RLAY pay a dividend?
As of September 2025 RLAY does not pay a dividend.How often does RLAY pay dividends?
Over the last 12 months, RLAY has issued dividend payments.Will RLAY pay dividends in 2025?
The next Ex-Dividend date for Relay Therapeutics (RLAY) is currently unknown.What is the next Ex-Dividend Date for RLAY?
The next Ex-Dividend date for Relay Therapeutics (RLAY) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of RLAY?
RLAY's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of RLAY?
RLAY's 5-Year Yield on Cost is -%. If you bought RLAY's shares at 36.93 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of RLAY?
RLAY Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does RLAY have a good Dividend Yield?
RLAY`s 0.00% Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of RLAY?
The Dividend Payout Ratio of RLAY is unknown.What is the Dividend Rating of RLAY?
RLAY`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-08-15 02:46